Literature DB >> 22683913

Influence of substrate on corneal epithelial cell viability within ocular surface models.

Yun Feng1, James Foster, Shengli Mi, Bo Chen, Che John Connon.   

Abstract

Corneal tissue engineering has improved dramatically over recent years. It is now possible to apply these technological advancements to the development of superior in vitro ocular surface models to reduce animal testing. We aim to show the effect different substrates can have on the viability of expanded corneal epithelial cells and that those which more accurately mimic the stromal surface provide the most protection against toxic assault. Compressed collagen gel as a substrate for the expansion of a human epithelial cell line was compared against two well-known substrates for modelling the ocular surface (polycarbonate membrane and conventional collagen gel). Cells were expanded over 10 days at which point cell stratification, cell number and expression of junctional proteins were assessed by electron microscopy, immunohistochemistry and RT-PCR. The effect of increasing concentrations of sodium lauryl sulphate on epithelial cell viability was quantified by MTT assay. Results showed improvement in terms of stratification, cell number and tight junction expression in human epithelial cells expanded upon either the polycarbonate membrane or compressed collagen gel when compared to a the use of a conventional collagen gel. However, cell viability was significantly higher in cells expanded upon the compressed collagen gel. We conclude that the more naturalistic composition and mechanical properties of compressed collagen gels produces a more robust corneal model.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22683913     DOI: 10.1016/j.exer.2012.05.005

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  8 in total

1.  Acellular ostrich corneal stroma used as scaffold for construction of tissue-engineered cornea.

Authors:  Xian-Ning Liu; Xiu-Ping Zhu; Jie Wu; Zheng-Jie Wu; Yong Yin; Xiang-Hua Xiao; Xin Su; Bin Kong; Shi-Yin Pan; Hua Yang; Yan Cheng; Na An; Sheng-Li Mi
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

2.  The core planar cell polarity gene, Vangl2, directs adult corneal epithelial cell alignment and migration.

Authors:  Amy S Findlay; D Alessio Panzica; Petr Walczysko; Amy B Holt; Deborah J Henderson; John D West; Ann M Rajnicek; J Martin Collinson
Journal:  R Soc Open Sci       Date:  2016-10-19       Impact factor: 2.963

3.  Tissue-engineered cornea constructed with compressed collagen and laser-perforated electrospun mat.

Authors:  Bin Kong; Wei Sun; Guoshi Chen; Song Tang; Ming Li; Zengwu Shao; Shengli Mi
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

4.  Cornea organoids from human induced pluripotent stem cells.

Authors:  James W Foster; Karl Wahlin; Sheila M Adams; David E Birk; Donald J Zack; Shukti Chakravarti
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

5.  Engineering of Corneal Tissue through an Aligned PVA/Collagen Composite Nanofibrous Electrospun Scaffold.

Authors:  Zhengjie Wu; Bin Kong; Rui Liu; Wei Sun; Shengli Mi
Journal:  Nanomaterials (Basel)       Date:  2018-02-24       Impact factor: 5.076

6.  Contact-mediated control of radial migration of corneal epithelial cells.

Authors:  Petr Walczysko; Ann M Rajnicek; J Martin Collinson
Journal:  Mol Vis       Date:  2016-08-09       Impact factor: 2.367

7.  Bioprinting three-dimensional cell-laden tissue constructs with controllable degradation.

Authors:  Zhengjie Wu; Xin Su; Yuanyuan Xu; Bin Kong; Wei Sun; Shengli Mi
Journal:  Sci Rep       Date:  2016-04-19       Impact factor: 4.379

8.  Constructing a Novel Three-Dimensional Biomimetic Corneal Endothelium Graft by Culturing Corneal Endothelium Cells on Compressed Collagen Gels.

Authors:  Yu-Jie Cen; Yun Feng
Journal:  Chin Med J (Engl)       Date:  2018-07-20       Impact factor: 2.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.